Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen PredictionJulia Kodysh, Alex RubinsteynProgress in Molecular Biology and Translational Science|August 7, 2019
Bioinformatic methods for cancer neoantigen predictionSebastian Boegel, John C Castle, Julia Kodysh, et al.Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.Cell Reports|December 28, 2018
Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in CancerMonica M Olcina, Nikolas G Balanis, Ryan K Kim, et al.Nature Cancer|May 9, 2025
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trialMansi Saxena, Jonathan F Anker, Julia Kodysh, et al.Biorxiv : the Preprint Server for Biology|June 25, 2020
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2Christof C Smith, Sarah Entwistle, Caryn Willis, et al.Cancers|June 10, 2022
Association between Incidental Pelvic Inflammation and Aggressive Prostate CancerDimple Chakravarty, Parita Ratnani, Li Huang, et al.Genome Medicine|June 15, 2021
Landscape and selection of vaccine epitopes in SARS-CoV-2Christof C Smith, Kelly S Olsen, Kaylee M Gentry, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.Cancer Discovery|March 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant SettingMansi Saxena, Thomas U Marron, Julia Kodysh, et al.Pageof 2